SCHEMBL15878933

SCHEMBL15878933

N#CCC(O)CSc1nnnn1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.55
▸ POLB P06746 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ TSHR P16473 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ GAA P10253 1/20 0.51
▸ TDP1 Q9NUW8 3/20 0.50
▸ PKM P14618 3/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14635219 1.00 ALDH1A1 (0.55) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL2377572 0.81 POLB (0.67) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL14635548 0.80 ALDH1A1 (0.52) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL15879018 0.80 ALDH1A1 (0.52) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL11126118 0.79 ALDH1A1 (0.65) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL11219399 0.79 ALDH1A1 (0.61) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL9180266 0.77 ALDH1A1 (0.61) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL14635604 0.77 ALDH1A1 (0.61) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL10478322 0.76 ALDH1A1 (0.54) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL12532944 0.74 ALDH1A1 (0.61) ALDH1A1POLBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303001-B2 Intermediate of statin drugs and preparation thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-04-05 — — US disclosed
US-20140206883-A1 INTERMEDIATE OF STATIN DRUGS AND PREPARATION THEREOF YICHANG CHANGJIANG PHARMACEUTICAL CO., LTD. (CN) 2014-07-24 — — US disclosed
CN-103649068-A Statin drug intermediate and preparation method thereof GUANGDONG HEC PHARMACEUTICAL 2014-03-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206883-A1 INTERMEDIATE OF STATIN DRUGS AND PREPARATION THEREOF HMGCR, SULT1E1, CYP3A5 ALDH1A1 307/4885POLB 2567/4885MAPT 2789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback